Aspire Biopharma Holdings, Inc. (ASBP) vs Kiora Pharmaceuticals, Inc. (KPRX)

Aspire Biopharma Holdings, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Aspire Biopharma Holdings, Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($12.2M and $11.8M). Kiora Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Aspire Biopharma Holdings, Inc. trades at 0.2×. Kiora Pharmaceuticals, Inc. has the higher net margin (0.00% vs −11,309.3%) and the lower return on invested capital (−44,053.9% vs 0.00%). Across the 15 metrics below, Kiora Pharmaceuticals, Inc. leads on 10 and Aspire Biopharma Holdings, Inc. on 5.

Valuation

Metric ASBP KPRX Biotechnology median
P/E 0.23 n/m 7.88
P/S 88.39 0.87 11.47
P/B 0.73 0.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.05 0.74
EV/Sales (7.59) (0.03) 10.73
Earnings yield 436.88% (94.06%) (28.84%)
Free cash flow yield (83.22%) (53.02%) (23.03%)

Profitability

Metric ASBP KPRX Biotechnology median
Gross margin (24.97%) 85.06% 65.16%
Operating margin (7,491.61%) 0.00% 0.00%
Net margin (11,309.31%) 0.00% 0.00%
Free cash flow margin (7,355.07%) 0.00% 0.00%
Return on equity (1,032.15%) (56.36%) (57.72%)
Return on assets (152.09%) (39.43%) (49.22%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric ASBP KPRX Biotechnology median
Revenue growth (TTM) — 983.73% 5.64%
EPS growth (last fiscal year) (762.74%) (403.45%) —
Revenue growth, 5-year CAGR — 88.72% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ASBP KPRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 8.97 4.73
Net debt to EBITDA (0.16) 1.33 0.96

Dividend

Metric ASBP KPRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ASBP KPRX Biotechnology median
Market cap 12.20m 11.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack